
New Arglaes Powder with Controlled-Release Silver for the Care of Chronic Wounds
When Arglaes film dressing featuring controlled release antimicrobial silver was first introduced in the United States a few years ago, physicians at prominent medical facilities, such as New York University Medical Center and Cleveland Clinic Heart Center, called it a significant development in the battle against infection. Arglaes in a powder form was recently launched, and it has greater application in helping to fight antibiotic-resistant bacteria, especially in deep, hard-to-treat wounds. Arglaes has no known resistance, it has no known major side effects, and it maintains an effective antimicrobial barrier for up to five days.
Since it is in a powder form, Arglaes Powder delivers controlled-release antimicrobial silver to any size, shape, or depth wound. Utilizing controlled-release polymers, Arglaes Powder delivers a constant stream of silver ions into the wound. This technology creates a barrier environment hostile to most known bacteria and fungi but remains completely safe to healthy cells.
In addition, Arglaes Powder contains alginate to aid in fluid handling. As the powder mixes with wound exudate, it turns into a gel that adheres to the wound bed and is easily removed during wound irrigation.
Arglaes Powder is ideal for use on difficult-to-dress exudating wounds where a traditional dressing may be difficult to apply. Wound types that benefit from Arglaes Powder include pressure ulcers, arterial ulcers, venous ulcers, diabetic ulcers, donor sites, dermal lesions, trauma injuries, incisions, and minor burns.
Currently, Arglaes is available in a powder, a transparent film dressing, and an island dressing with an alginate pad for moist wounds.
Arglaes is exclusively distributed in the United States by Medline Industries, Inc. For more information, contact Medline Industries, Inc. at 1-800-Medline.
Ferris Mfg. Corp. Introduces New Addition to PolyMem Family of Dressings
Ferris Mfg. Corp., creator of PolyMem®, "The Pink Dressing®," announces the addition of a new product to the PolyMem® family of dressings--PolyMax(TM).
PolyMax is a thicker version of PolyMem, a hydrophilic polyurethane membrane with semipermeable thin film backing. PolyMax, which is 60 percent more absorbent than low-profile PolyMem, extends time between dressing changes and reduces the number of necessary dressing changes, very important elements for managing deep, extensive wounds.
The variety of products in the PolyMem, "The Pink Dressing," selection of products is designed to work with the body's wound fluids, which are known to contain natural growth factors and nutrients. All PolyMem products combine superabsorbent elements with moisturizers and cleansers designed to help patients achieve maximum healing capabilities, speeding the healing process and reducing long-term costs.
Ferris Mfg. Co., based in Burr Ridge, Illinois, offers information on all Ferris products via their website, www.FerrisCares.com [2].
Hyperion® SCE(TM)--The All-in-One Solution for Incontinence Skin Care
Hyperion® SCE(TM), from the wound and skin care specialists at Hyperion Medical Inc., is a waterless skin-cleansing emollient for use with incontinent patients. Soap free and scientifically formulated, Hyperion SCE hydrates, nurtures, and protects skin with every cleansing. It can eliminate multiple skin care products, reducing associated care costs.
For more information, visit www.hyperionmedical.com [3].
Links:
[1] http://www.woundsresearch.com/issue/volume-14-issue-7-july-2002
[2] http://www.FerrisCares.com
[3] http://www.hyperionmedical.com
[4] http://www.woundsresearch.com/printmail/710
[5] http://www.woundsresearch.com/print/710
[6] http://www.woundsresearch.com/contentlinks